Alzheimer’s Disease Today and Tomorrow: Optimal Treatment and Collaborative Care

This multidisciplinary activity will examine effective management strategies and optimal therapy for cognitive and neuropsychiatric symptoms.
Carolyn K. Clevenger, RN, DNP, AGPCNP-BC, GNP-BC, FAANP
Lori A. Daiello, PharmD, ScM
Laeth Nasir, MBBS
Anton P. Porsteinsson, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: March 29, 2019 Expiration: March 29, 2020

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Discuss currently available agents for the management of the cognitive symptoms of Alzheimer’s disease.
  • Develop strategies for managing agitation and depression in patients with Alzheimer’s disease.
  • Describe agents in late-stage development for the prevention and management of Alzheimer’s disease.
  • Incorporate collaborative care strategies to create a management plan for patients with Alzheimer’s disease.

Information on this Educational Activity

Faculty

Anton P. Porsteinsson, MD

William B. and Sheila Konar Professor of Psychiatry
University of Rochester School of Medicine and Dentistry
Alzheimer’s Disease Care, Research and Education Program (AD-CARE)
University of Rochester Medical Center
Monroe Community Hospital
Rochester, New York

Anton Porsteinsson, MD, discloses the following conflicts of interest. Grant/research: AstraZeneca, Avanir, Biogen, Biohaven, Eisai, Lilly, Genentech/Roche, Janssen, Merck, Novartis Consultant/advisory board: Acadia, Alzheon, Functional Neuromodulation, Neurim
Lori A. Daiello, PharmD, ScM

Assistant Professor of Neurology
Brown University Alpert Medical School
Assistant Professor of Health Services, Policy & Practice
Brown University School of Public Health
Providence, Rhode Island

Lori Daiello, PharmD, ScM, has no conflicts of interest to disclose.
Carolyn K. Clevenger, RN, DNP, AGPCNP-BC, GNP-BC, FAANP

Associate Dean for Clinical and Community Partnerships
Professor,
Nell Hodgson Woodruff School of Nursing at Emory University
Integrated Memory Care Clinic/Brain Health Center
Emory Healthcare
Atlanta, Georgia

Carolyn K. Clevenger, RN, DNP, AGPCNP-BC, GNP-BC, FAANP, has no conflicts of interest to disclose.
Laeth Nasir, MBBS

Professor of Medicine
Associate Dean for Community Medicine
Creighton University School of Medicine
Omaha, Nebraska

Laeth Nasir, MBBS, discloses that his spouse has served as a consultant for Pfizer Inc.

Susan P. Tyler, MEd, CMP, CHCP, CME Director, University of Cincinnati, has no conflicts of interest to disclose.

Bruce C. Gebhardt, MD, CME Reviewer-Compliance, University of Cincinnati, has no conflicts of interest to disclose.

Heather Muskopf, Program Manager, Continuing Medical Education, University of Cincinnati, has no conflicts of interest to disclose.

Kathleen Hines, Vice President, Editorial Services, MCM Education, has no conflicts of interest to disclose.

The credit providers require all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

In this educational activity, the faculty reports that their presentation will not contain reference to investigational and/or off-label uses.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Target Audience

Physicians, advanced practice nurses, physician assistants, and consultant or senior care pharmacists who care for older adults.

Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity was developed through the joint providership of the University of Cincinnati and MCM Education.

ACCME Accreditation Support:
Please contact the University of Cincinnati Continuing Medical Education Department at uccme@uc.edu or call 513-558-7277.

Nursing Continuing Education

This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ), the Gerontological Advanced Practice Nurses Association (GAPNA), the University of Cincinnati, the American Society of Consultant Pharmacists, and MCM Education.

Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.

Nursing Learning Outcome
After attending this session, the learner will be able to outline optimal treatment and management of Alzheimer’s disease.

Pharmacist Continuing Education

The American Society of Consultant Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity, ACPE UAN 0203-9999-19-034-H01-P is approved for 1.0 contact hour. Participants must view the activity in its entirety, complete the post-test (80% or higher) and evaluation to receive CPE credit. Initial Release Date: March 29, 2019, Expiration Date: March 29, 2020.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 29, 2019, through March 29, 2020:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 80% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

CME/CE-certified CCO video capturing live webinar on managing heart failure in older adults with experts Gregg C. Fonarow, MD; Margaret Bowers, DNP, FNP-BC; Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, FASCP, FAzPA

person default Margaret Bowers, DNP, FNP-BC person default Gregg C. Fonarow, MD person default Elizabeth Pogge, PharmD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 18, 2020 Expired: May 17, 2021

Concise CCO activity on selecting second-generation antipsychotics for treatment augmentation in patients with MDD and managing adverse events

Rakesh Jain, MD, MPH Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: May 7, 2020 Expired: May 6, 2021

Free slides from CCO and Rakesh Jain, MD, MPH: Expert insights on efficacy, role of antipsychotics in MDD, mitigating and manage adverse events

Rakesh Jain, MD, MPH Released: May 7, 2020

CCO downloadable PDF: Evidence and expert answers on continuous glucose monitoring (CGM)

Vivian A. Fonseca, MD, FRCP
Program Director
Kushner_Pamela_32x32 Pamela Kushner, MD, FAAFP
Released: April 22, 2020
Provided by the University of Cincinnati

ACCME Accreditation Support:
Please contact the University of Cincinnati Continuing Medical Education Department at uccme@uc.edu or call 513-558-7277

Provided by Gerontological Advanced Practice Nurses Association
Provided by The American Society of Consultant Pharmacists
Telephone: 703-739-1300 or 800-355-2727
This activity is supported by an educational grant from
Biogen

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?